Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Jurnal Ilmiah Kesehatan (JIKA)
Nasution, Malayana R.
Unknown Affiliation
Health Professions Medicine & Pharmacology Nursing Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Bcr-Abl1 Transcript Variants in Chronic Myeloid Leukemia Patients: Relationship with Routine Hematological Parameters Sela, Grace; Aman, Adi Koesoema; Nasution, Malayana R.
Jurnal Ilmiah Kesehatan (JIKA) Vol. 7 No. 3 (2025): Volume 7 Nomor 3 Desember 2025
Publisher : Sarana Ilmu Indonesia (salnesia)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36590/jika.v7i3.1644

Abstract

Chronic myeloid leukemia (CML) was a myeloproliferative neoplasm characterized by the Philadelphia chromosome resulting from the BCR-ABL1 translocation. The most common BCR-ABL1 transcript variants were b2a2 and b3a2, which encoded the p210 protein with increased tyrosine kinase activity. This study was an analytical observational study with a cross-sectional design using retrospective data obtained from medical records. The study analyzed the relationship between BCR-ABL1 transcript variants and routine hematological parameters (hemoglobin, leukocyte count, and platelet count) among CML patients at Adam Malik General Hospital from 2020 to 2024 using a total sampling method. A total of 38 patients met the inclusion criteria, of whom 71,1% had the b3a2 variant and 28,9% had the b2a2 variant. Males predominated (60,5%), with a mean age of 28,37 ± 16,23 years. Leukocyte counts were significantly lower in patients with the b3a2 variant than in those with the b2a2 variant (p = 0,045), whereas hemoglobin and platelet levels showed no significant differences. A statistically significant relationship was found between leukocyte count and BCR-ABL1 transcript variants, while no significant relationship was observed between hemoglobin or platelet levels and transcript variants. The study highlighted the potential association between BCR-ABL1 transcript variants and leukocyte count in CML patients.
Co-Authors Adi Koesoema Aman, Adi Koesoema Sela, Grace